Monarch Partners Asset Management LLC Avrobio, Inc. Transaction History

Monarch Partners Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$7.84 - $12.6 $214,188 - $344,232	-27,320 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$10.54 - $19.3 $8,800 - $16,115	835 Added 3.15%	27,320 $347,000
Q4 2020 Feb 04, 2021	SELL	$12.79 - $17.1 $36,707 - $49,077	-2,870 Reduced 9.78%	26,485 $369,000
Q3 2020 Nov 05, 2020	BUY	$12.99 - $19.41 $122,885 - $183,618	9,460 Added 47.55%	29,355 $382,000
Q2 2020 Jul 31, 2020	BUY	$12.19 - $22.96 $242,520 - $456,789	19,895 New	19,895 $347,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Monarch Partners Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monarch Partners Asset Management LLC with notifications on news.